These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 715242)

  • 1. [Evaluation of beta-adrenolytic treatment of essential hypertension with the use of visken (author's transl)].
    Lukasik S; Halawa B; Surowiak M; Kasprzak J
    Przegl Lek; 1978; 35(7):637-41. PubMed ID: 715242
    [No Abstract]   [Full Text] [Related]  

  • 2. [Controlled study of high blood pressure treatment using betablocker Visken (author's transl)].
    Ripka O; Linhartová J; Jarolím M; Okrouhlík B; Chvatíková J
    Sb Lek; 1975 Oct; 77(10):294-7. PubMed ID: 1101360
    [No Abstract]   [Full Text] [Related]  

  • 3. [Prolonged antihypertensive effect of beta-adrenolytic treatment with Visken in patients with essential hypertension].
    Lukasik S; Halawa B; Surowiak M; Kasprzak J
    Pol Tyg Lek; 1977 Nov; 32(47):1837-9. PubMed ID: 341096
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pindolol in arterial hypertension. A double-blind study (author's transl)].
    Basso B; Roman O
    Rev Med Chil; 1976 Mar; 104(3):143-7. PubMed ID: 781772
    [No Abstract]   [Full Text] [Related]  

  • 5. [Visken in the treatment of arterial hypertension].
    Sznajderman M; Brym E
    Pol Tyg Lek; 1975 Dec; 30(50):2105-7. PubMed ID: 1197105
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical use of pindolol (Visken) in the treatment of arterial hypertension].
    Lambić IS; Krstić Lj
    Srp Arh Celok Lek; 1977 Feb; 105(2):191-200. PubMed ID: 905885
    [No Abstract]   [Full Text] [Related]  

  • 7. [A controlled clinical therapeutic trial of prindolol in patients with arterial hypertension (author's transl)].
    Marinković M; Winter-Fudurić ; Kuzmanić D
    Lijec Vjesn; 1976 Apr; 98(4):172-6. PubMed ID: 787710
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lowering of the blood pressure and renin suppression by beta receptor blockade with Visken in patients with borderline hypertension (author's transl)].
    Werning C
    Med Klin; 1973 Nov; 68(47):1559-63. PubMed ID: 4781097
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical studies on application of Visken in treatment of coronary disease (author's transl)].
    Ziólkowski L; Ilmurzyńska K
    Przegl Lek; 1973; 30(9):771-5. PubMed ID: 4587262
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)].
    Persson I; Ulrich J
    Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of visken in hypertension associated with ischemic heart disease and nutritional obesity].
    Khomenko VL; Vasiuk IuA; Romashkin AV; Sivkov SI; Mel'nikov AIu; Buskin VD
    Sov Med; 1990; (3):64-7. PubMed ID: 2195673
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of pindolol (Visken) on blood pressure and plasma renin activity in various forms of hypertension].
    Werning C; Vetter H
    Adv Clin Pharmacol; 1976; 11():54-60. PubMed ID: 1032571
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Ambulatory treatment of so-called "essential" arterial hypertension with pindolol. Short-term study].
    Reffo GC; Pitzorno G; Perin S; Forattini C
    Minerva Med; 1980 Jan; 71(1):49-54. PubMed ID: 6101911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of mild and moderate hypertension with viskaldix (author's transl)].
    Voges D; Fryda-Kaurimsky Z
    Schweiz Rundsch Med Prax; 1978 Oct; 67(42):1554-7. PubMed ID: 704550
    [No Abstract]   [Full Text] [Related]  

  • 15. Combination therapy of essential hypertension with pindolol (Visken) and hydralazine.
    Persson I
    Adv Clin Pharmacol; 1976; 11():1114-8. PubMed ID: 802071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Essential arterial hypertension. Antihypertensive effect of the beta adrenergic blockader pindolol].
    Torres Zamora M
    Prensa Med Mex; 1977; 42(3-4):127-32. PubMed ID: 917991
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of hypertension with the beta-receptor-antagonist pindolol (Viskèn). A comparison with chlorthalidone (Hygroton)].
    Schaffalitzky de Muckadel ; Gyntelberg F
    Ugeskr Laeger; 1973 May; 135(20):971-4. PubMed ID: 4585570
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pindolol in benign essential hypertension. A group study by 12 Zürich internists].
    Rhomberg F; Bächtold H; Danczkay I; Hugentobler F; Jaccard G; Kälin R; Pugatsch I; Stauffenegger M; Veraguth F; Waldvogel W
    Schweiz Med Wochenschr; 1979 Jun; 109(26):990-4. PubMed ID: 462166
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pindolol in the treatment of arterial hypertension].
    Lekieffre J; Dewailly Ph
    Lille Med; 1977 Apr; 22(4 Suppl 1):275-9. PubMed ID: 327176
    [No Abstract]   [Full Text] [Related]  

  • 20. [Long-term management of arterial hypertension using a beta-adrenolytic agent in combination with a saluretic].
    Fryda-Kaurimsky Z; Krüger K; Krüger K
    Med Welt; 1979 Apr; 30(15):572-5. PubMed ID: 449649
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.